LEXEO THERAPEUTICS
LEXEO Therapeutics is a fully integrated biotechnology company. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine. Beyond LEXEO Therapeutics’ lead programs – which are focused on both rare and non-rare monogenic (single genemutation) diseases – the company’s preclinical pipeline spans monogenic diseases, as well as hereditary and acquired diseases across a spectrum o... f patient population sizes and a range of unmet medical needs. Importantly, LEXEO Therapeutics will focus on advancing clinical programs through to commercialization, with the goal of maintaining an ongoing research collaboration with Weill Cornell Medicine’s Department of Genetic Medicine to help advance the company’s pre-clinical pipeline.
LEXEO THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2018-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.lexeotx.com
Total Employee:
11+
Status:
Active
Contact:
(212) 547-9879
Email Addresses:
[email protected]
Total Funding:
185 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Asgard Therapeutics
Asgard Therapeutics is a Biotechnology Company.
CuraSen Therapeutics
CuraSen Therapeutics is a biopharmaceutical company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Faze Medicines
Faze Medicines is a biotechnology company.
Immunicom
Immunicom is a biotechnology company.
Libra Therapeutics
Libra Therapeutics is a biotechnology company.
MOMA Therapeutics
MOMA Therapeutics operates as a biotechnology company.
Primmune Therapeutics
Primmune Therapeutics is a Biotechnology company.
Rekindle Therapeutics
Rekindle Therapeutics is a biotechnology company.
Terray Therapeutics
Terray Therapeutics is a biotechnology company that propels drug discovery into the information age.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Xios Therapeutics
Xios Therapeutics is a biotechnology company .
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-07-21 | Stelios Therapeutics | Stelios Therapeutics acquired by LEXEO Therapeutics | N/A |
Investors List
Janus Henderson Investors
Janus Henderson Investors investment in Series B - LEXEO Therapeutics
Gray’s Creek Capital Partners
Gray’s Creek Capital Partners investment in Series B - LEXEO Therapeutics
Omega Funds
Omega Funds investment in Series B - LEXEO Therapeutics
Eventide
Eventide investment in Series B - LEXEO Therapeutics
Verition Fund Management
Verition Fund Management investment in Series B - LEXEO Therapeutics
Laurion Capital Management
Laurion Capital Management investment in Series B - LEXEO Therapeutics
Intus Capital
Intus Capital investment in Series B - LEXEO Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - LEXEO Therapeutics
CAM Capital
CAM Capital investment in Series B - LEXEO Therapeutics
D1 Capital Partners
D1 Capital Partners investment in Series B - LEXEO Therapeutics
Official Site Inspections
http://www.lexeotx.com Semrush global rank: 528.08 K Semrush visits lastest month: 91.71 K
- Host name: vps34638.dreamhostps.com
- IP address: 67.205.19.65
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "LEXEO Therapeutics"
Lexeo Therapeutics
Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, we partner with preeminent institutions on the cutting edge of gene therapy …See details»
About Us - Lexeo Therapeutics
Based in New York City, Lexeo is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.See details»
Lexeo Patients & Community
Lexeo is extremely proud to partner with patient advocacy groups and non-profit organizations to support, educate, and advocate for the communities we serve.See details»
Team - Lexeo Therapeutics
Lexeo’s management team consists of pioneers and driven leaders with decades of development experience in gene therapy and rare diseases. R. Nolan Townsend has served as Lexeo …See details»
Lexeo Patients & Community – Expanded Access
At Lexeo Therapeutics, we are dedicated to developing gene therapies that will transform the lives of patients with serious debilitating and/or life-threatening diseases.See details»
Lexeo Patients & Community – Clinical Trials
Lexeo is conducting gene therapy clinical trials in: To learn more about these diseases and the Lexeo's clinical programs, read below. Interested in learning more about our programs or …See details»
Documents & Charters - Lexeo Therapeutics
Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the …See details»
Lexeo Therapeutics, Inc. (LXEO) - Yahoo Finance
See the company profile for Lexeo Therapeutics, Inc. (LXEO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
LEXEO Therapeutics - Crunchbase Company Profile & Funding
LEXEO Therapeutics is a fully integrated biotechnology company. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill …See details»
Lexeo Therapeutics
Oct 22, 2023 · The Investor Relations website contains information about Lexeo Therapeutics's business for stockholders, potential investors, and financial analysts.See details»
Our approach - Lexeo Therapeutics
Build a fully integrated genetic medicine company and selectively evaluate strategic opportunities to maximize the impact of our pipeline.See details»
LEXEO Therapeutics Launches with $85 Million Series A Financing …
Rare disease and gene therapy industry veterans Steven Altschuler, M.D., R. Nolan Townsend, and Jay Barth, M.D., team up with gene therapy pioneer Ronald Crystal, M.D., to launch fully …See details»
LEXEO Therapeutics Strengthens Management Team with Key …
NEW YORK, April 06, 2021 (GLOBE NEWSWIRE) -- LEXEO Therapeutics, a clinical-stage gene therapy company, today announced the continued expansion of its management team with the …See details»
LEXEO Therapeutics Strengthens Management Team with Key …
Our corporate priorities is building a world-class gene therapy organization, and we are thrilled to announce the appointments of two senior leaders, both with prior experience in the gene …See details»
Lexeo Patients & Community – Gene Therapy
Genes are pieces of DNA in the chromosomes that are responsible for determining everything from physical traits, like eye color, to how our bodies work every day. One important role of …See details»
Lexeo Therapeutics Announces Positive Interim Data for LX1001, …
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically …See details»
Lexeo Therapeutics Announces Positive Interim Data for LX1001, …
Oct 30, 2024 · Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to …See details»
LX2006 - Lexeo Therapeutics
Friedreich’s ataxia is a genetic, progressive, degenerative multi-system disorder with a prevalence of one in 50,000 in the United States. It is estimated that approximately 80% of these patients …See details»
LXEO Stock Price Quote | Morningstar
Nov 20, 2024 · See the latest Lexeo Therapeutics Inc stock price (LXEO:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
Careers - Lexeo Therapeutics
Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how …See details»